Cargando…
Treatment of Gastric Cancer Patients During COVID-19 Pandemic: The West is More Vulnerable
The outbreak of the COVID-19 is currently the biggest international concern. Treatment of gastric cancer (GC) patients in the pandemic era with high hospital burden and under severe oncological/surgical resource constraints should implicate a need for resource re-allocation with a new “pandemic” GC...
Autores principales: | Polkowski, Wojciech Piotr, Sędłak, Katarzyna, Rawicz-Pruszyński, Karol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402851/ https://www.ncbi.nlm.nih.gov/pubmed/32801886 http://dx.doi.org/10.2147/CMAR.S260842 |
Ejemplares similares
-
Mixed Type Histology as a Predictive Factor for Esophagojejunostomy Leak in Advanced Gastric Cancer
por: Rawicz-Pruszyński, Karol, et al.
Publicado: (2020) -
Rapid Detection of Free Cancer Cells in Intraoperative Peritoneal Lavage Using One-Step Nucleic Acid Amplification (OSNA) in Gastric Cancer Patients
por: Gęca, Katarzyna, et al.
Publicado: (2020) -
Molecular Cytology by One-Step Nucleic Acid Amplification (OSNA) Assay of Peritoneal Washings during D2 Gastrectomy in Advanced Gastric Cancer Patients: Preliminary Results
por: Gęca, Katarzyna, et al.
Publicado: (2021) -
Lymph Node Involvement in Advanced Gastric Cancer in the Era of Multimodal Treatment—Oncological and Surgical Perspective
por: Pelc, Zuzanna, et al.
Publicado: (2021) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes
por: Mielko, Jerzy, et al.
Publicado: (2020)